Proficio Capital Partners LLC Takes Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Proficio Capital Partners LLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 30,780 shares of the company's stock, valued at approximately $404,000.

Other institutional investors have also recently made changes to their positions in the company. Quest Partners LLC boosted its stake in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after acquiring an additional 622 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares in the last quarter. Quarry LP grew its holdings in Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after purchasing an additional 1,662 shares during the period. Smartleaf Asset Management LLC increased its position in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after buying an additional 6,090 shares in the last quarter. Finally, FMR LLC raised its stake in shares of Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company's stock worth $114,000 after buying an additional 6,771 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several equities analysts have recently commented on MD shares. UBS Group boosted their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. Truist Financial upped their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research note on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, Macquarie began coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an "outperform" rating and a $18.00 target price for the company. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Pediatrix Medical Group currently has an average rating of "Hold" and an average target price of $17.08.

Pediatrix Medical Group Price Performance

MD stock traded down $0.87 during trading on Friday, hitting $14.15. 670,815 shares of the company's stock traded hands, compared to its average volume of 837,310. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.79, a P/E/G ratio of 1.74 and a beta of 1.49. The business has a fifty day simple moving average of $14.39 and a 200 day simple moving average of $13.62. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, research analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.